EGFR and glioblastoma: A study by our group demonstrated that the AMPK activator, 5-aminoimidazole-4-carboxamide-1-β-d-ribonucleoside (AICAR) effectively blocks the growth of EGFR-activated GBM primarily by inhibiting lipogenesis [84] (Figure 4).